Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug
Abstract Bisphosphonates have benefits in breast cancer and multiple myeloma patients and have been used with adoptive immunotherapy with γδ T cells expressing Vγ2 Vδ2 TCRs. Although treatment with γδ T cells is safe, it has shown limited efficacy. Present bisphosphonates stimulate γδ T cells but we...
Guardado en:
Autores principales: | Yoshimasa Tanaka, Masashi Iwasaki, Kaoru Murata-Hirai, Kenji Matsumoto, Kosuke Hayashi, Haruki Okamura, Tomoharu Sugie, Nagahiro Minato, Craig T. Morita, Masakazu Toi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9f0bf342bae840ad95d227a5c3a671ad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunotherapeutic Advances for NSCLC
por: Massafra M, et al.
Publicado: (2021) -
Novel Immunotherapeutic Approach in Gastric Cancer
por: Gulubova M., et al.
Publicado: (2020) -
Evaluation of Mandibular Morphometry in the Bisphosphonate Users
por: Busra,Tanrikol, et al.
Publicado: (2019) -
Epigenomics and immunotherapeutic advances in pediatric brain tumors
por: Malak Abedalthagafi, et al.
Publicado: (2021) -
Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon
por: O'Donnell KL, et al.
Publicado: (2021)